Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Fukuchi, K.
Right arrow Articles by Ohura, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuchi, K.
Right arrow Articles by Ohura, K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Oral Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Apoptosis in Human Oral Squamous Cell Carcinomas is Induced by 15-Deoxy-{Delta}12,14-Prostaglandin J2 but not by Troglitazone

K. Fukuchi1, M. Date2,3,*, Y. Azuma2, M. Shinohara2, H. Takahashi3 and K. Ohura2

1 First Department of Oral and Maxillofacial Surgery, Osaka Dental University, Hirakata, Japan;
2 Department of Pharmacology, Osaka Dental University, 8-1, Kuzuhahanazono-cho, Hirakata, Osaka 573-1121, Japan; and
3 Institute of Clinical Medicine and Research, Jikei University School of Medicine, Kashiwa, Japan;


Figure 1
View larger version (73K):
[in this window]
[in a new window]

 
Figure 1. PPAR-{gamma} protein expression in SAS and HSC-4 cells. (A) Western blot analysis. (B) Immunocytochemistry. Results shown are from one representative experiment from a total of 3 performed. Scale bar = 10 µm.

 

Figure 2
View larger version (29K):
[in this window]
[in a new window]

 
Figure 2. Effects of 15-d-PGJ2 and troglitazone on cell viability. Cells were incubated with various concentrations of 15-d-PGJ2 and trogiltazone for 36 hrs (A) and with 20 µM 15-d-PGJ2 and troglitazone for the indicated periods of time (B). Cell viability was determined by a modified MTT assay and expressed as a percentage of viability under control culture conditions. Data are expressed as mean ± SD (n = 3). *p < 0.05, **p < 0.01.

 

Figure 3
View larger version (51K):
[in this window]
[in a new window]

 
Figure 3. Detection of apoptosis in human oral SCC cell lines. (A) TUNEL staining in human oral SCC cell lines. A TUNEL assay was performed 24 hrs after 20 µM of 15-d-PGJ2 or troglitazone treatment. The results shown are from a representative experiment from a total of 3 that were performed. Scale bar = 10 µm. (B) Effect of 15-d-PGJ2 or troglitazone on intracellular nucleosome enrichment. The nucleosome concentration after 20 µM of 15-d-PGJ2 or troglitazone treatment was examined with a cell-death detection kit for the indicated periods of time. Control cells were assigned a value of 1, and other values were expressed relative to these and were plotted against the time after treatment. Data are expressed as mean ± SD (n = 3). *p < 0.05, **p < 0.01.

 

Figure 4
View larger version (23K):
[in this window]
[in a new window]

 
Figure 4. Effects on apoptotic signaling pathways by 15-d-PGJ2. Control cells were assigned a value of 1, and other values were expressed relative to these and were plotted against the time after 15-d-PGJ2 treatment. Data are expressed as mean ± SD (n = 3). *p < 0.05, **p < 0.01. (A) Caspase activation induced by 15-d-PGJ2. Cells were incubated with 20 µM 15-d-PGJ2 and troglitazone for the indicated periods of time. (B) Effects of caspase inhibitors on 15-d-PGJ2-induced apoptosis. Cells were treated with 20 µM 15-d-PGJ2 in the presence or absence of Z-VAD-FMK (2.5-20 µM), or Z-DEVD-FMK (2.5-20 µM) for 24 hrs. Then cells were processed for detection of fragmented mono- and oligonucleosomes by ELISA. (C) Cytochrome c release from mitochondria. Cells were incubated with 20 µM 15-d-PGJ2 for the indicated periods of time.

 

Journal of Dental Research, Vol. 82, No. 10, 802-806 (2003)
DOI: 10.1177/154405910308201008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?